Prevalence of Alzheimer's, Related Dementia Set to Double
FRIDAY, Sept. 21, 2018 -- The burden of Alzheimer's disease and related dementias (ADRD) is expected to increase to 3.3 percent in the United States by 2060, according to a study published online Sept. 19 in Alzheimer's & Dementia.
Kevin A. Matthews, Ph.D., from the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues estimated the future U.S. burden of ADRD by age, sex, race, and ethnicity. Subgroup-specific prevalence among Medicare fee-for service beneficiaries aged ≥65 years in 2014 was applied to subgroup-specific population estimates for 2014 and population projection data from the U.S. Census Bureau for 2015 to 2060.
The researchers estimated the burden of ADRD in 2014 at five million adults aged ≥65 years, or 1.6 percent of the population. Significant disparities were seen in the prevalence of ADRD among population subgroups defined by race and ethnicity. By 2060, the ADRD burden is expected to double to 3.3 percent, with 13.9 million Americans projected to have the disease.
"This study shows that as the U.S. population increases, the number of people affected by Alzheimer's disease and related dementias will rise, especially among minority populations," CDC Director Robert R. Redfield, M.D., said in a statement. "Early diagnosis is key to helping people and their families cope with loss of memory, navigate the health care system, and plan for their care in the future."
© 2020 HealthDay. All rights reserved.
Posted: September 2018
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.